Relay Therapeutics, Inc. · NASDAQ:RLAY
The Vanguard Group reported a 5.47% stake in Relay Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 29, 2025
The Vanguard Group reported a 5.47% stake in Relay Therapeutics, Inc., 9,379,851 shares, as a passive investor on Jun 30, 2025. Filed Jul 29, 2025 (Schedule 13G/A).
- Stake
- 5.47%
- Shares
- 9,379,851
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.47% | 9,379,851 |
Source
Related
- Relay Therapeutics, Inc.
- The Vanguard Group
- Relay Therapeutics, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026
- Schedule 13G/A · The Vanguard Group · Apr 30, 2025
- Form 4 · Patel Sanjiv · Oct 8, 2026
- Form 4 · Catinazzo Thomas · Oct 8, 2026
- Form 4 · Bergstrom Donald A · Sep 9, 2026
- Form 4 · Catinazzo Thomas · Sep 9, 2026
- Form 4 · Patel Sanjiv · Sep 9, 2026